A shift in the beta-blocker treatment paradigm has arrived with the changing myocardial infarction treatment landscape, said ...

DEAR DR. ROACH: I recently brought myself to the hospital because my electrocardiogram (EKG) result showed “possible ischemia ...

In the ABYSS trial, researchers found that interrupting a beta-blocker in patients after a myocardial infarction resulted in ...

Cardiovascular events are not significantly decreased with edetate disodium chelation in patients with CAD and history of myocardial infarction and diabetes.

Young patients with myocardial infarction (MI) and fewer traditional risk factors often have greater exposure to urban noise, ...

Personality traits can influence cardiovascular disease (CVD) risk with type 2 diabetes mellitus (T2DM), according to a study ...

On September 17, 2024, BioCardia received notice from Nasdaq confirming that the Company has demonstrated compliance with Listing Rule 5550 (b) (1) (the “Equity Rule”) of The Nasdaq Stock Market.

Long-term use of beta-blockers in patients with myocardial infarction and preserved heart function does not significantly ...

A study has found that sirolimus-coated balloons vs thin drug-eluting stents in in-stent restenosis show similar favorable clinical outcomes.

During a massive heart attack, a large portion of the heart doesn’t receive oxygen due to a blocked artery. Quick treatment ...

In a large meta-analysis, complete revascularisation reduced cardiovascular events compared with culprit-only revascularisation in older patients with a myocardial infarction and multivessel disease ...

Background In acute heart failure (HF), reduced cardiac output, vasoconstriction and congestion may damage the intestinal ...